BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 15882962)

  • 1. Interaction of the 106-126 prion peptide with lipid membranes and potential implication for neurotoxicity.
    Dupiereux I; Zorzi W; Lins L; Brasseur R; Colson P; Heinen E; Elmoualij B
    Biochem Biophys Res Commun; 2005 Jun; 331(4):894-901. PubMed ID: 15882962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 118-135 peptide of the human prion protein forms amyloid fibrils and induces liposome fusion.
    Pillot T; Lins L; Goethals M; Vanloo B; Baert J; Vandekerckhove J; Rosseneu M; Brasseur R
    J Mol Biol; 1997 Dec; 274(3):381-93. PubMed ID: 9405147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Membrane interactions and conformational preferences of human and avian prion N-terminal tandem repeats: the role of copper(II) ions, pH, and membrane mimicking environments.
    Di Natale G; Pappalardo G; Milardi D; Sciacca MF; Attanasio F; La Mendola D; Rizzarelli E
    J Phys Chem B; 2010 Nov; 114(43):13830-8. PubMed ID: 20936829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A neurotoxic and gliotrophic fragment of the prion protein increases plasma membrane microviscosity.
    Salmona M; Forloni G; Diomede L; Algeri M; De Gioia L; Angeretti N; Giaccone G; Tagliavini F; Bugiani O
    Neurobiol Dis; 1997; 4(1):47-57. PubMed ID: 9258911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clustered negative charges on the lipid membrane surface induce beta-sheet formation of prion protein fragment 106-126.
    Miura T; Yoda M; Takaku N; Hirose T; Takeuchi H
    Biochemistry; 2007 Oct; 46(41):11589-97. PubMed ID: 17887730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study on the toxic mechanism of prion protein peptide 106-126 in neuronal and non neuronal cells.
    Dupiereux I; Zorzi W; Rachidi W; Zorzi D; Pierard O; Lhereux B; Heinen E; Elmoualij B
    J Neurosci Res; 2006 Aug; 84(3):637-46. PubMed ID: 16786576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of prion protein to lipid membranes and implications for prion conversion.
    Sanghera N; Pinheiro TJ
    J Mol Biol; 2002 Feb; 315(5):1241-56. PubMed ID: 11827491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Core structure of amyloid fibrils formed by residues 106-126 of the human prion protein.
    Walsh P; Simonetti K; Sharpe S
    Structure; 2009 Mar; 17(3):417-26. PubMed ID: 19278656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence that the 127-164 region of prion proteins has two equi-energetic conformations with beta or alpha features.
    Derreumaux P
    Biophys J; 2001 Sep; 81(3):1657-65. PubMed ID: 11509378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The interaction of humic substances with the human prion protein fragment 90-231 affects its protease K resistance and cell internalization.
    Corsaro A; Anselmi C; Polano M; Aceto A; Florio T; De Nobili M
    J Biol Regul Homeost Agents; 2010; 24(1):27-39. PubMed ID: 20385069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tilted properties of the 67-78 fragment of alpha-synuclein are responsible for membrane destabilization and neurotoxicity.
    Crowet JM; Lins L; Dupiereux I; Elmoualija B; Lorin A; Charloteaux B; Stroobant V; Heinen E; Brasseur R
    Proteins; 2007 Sep; 68(4):936-47. PubMed ID: 17554782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of detergents on the secondary structures of prion protein peptides as studied by CD spectroscopy.
    Kuroda Y; Maeda Y; Sawa S; Shibata K; Miyamoto K; Nakagawa T
    J Pept Sci; 2003 Apr; 9(4):212-20. PubMed ID: 12725242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Copper and zinc promote interactions between membrane-anchored peptides of the metal binding domain of the prion protein.
    Kenward AG; Bartolotti LJ; Burns CS
    Biochemistry; 2007 Apr; 46(14):4261-71. PubMed ID: 17371047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular model of an alpha-helical prion protein dimer and its monomeric subunits as derived from chemical cross-linking and molecular modeling calculations.
    Kaimann T; Metzger S; Kuhlmann K; Brandt B; Birkmann E; Höltje HD; Riesner D
    J Mol Biol; 2008 Feb; 376(2):582-96. PubMed ID: 18158160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of prion peptide structure and aggregation in toxicity and membrane binding.
    Rymer DL; Good TA
    J Neurochem; 2000 Dec; 75(6):2536-45. PubMed ID: 11080207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NMR solution structure of the peptide fragment 1-30, derived from unprocessed mouse Doppel protein, in DHPC micelles.
    Papadopoulos E; Oglecka K; Mäler L; Jarvet J; Wright PE; Dyson HJ; Gräslund A
    Biochemistry; 2006 Jan; 45(1):159-66. PubMed ID: 16388591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PrP N-terminal domain triggers PrP(Sc)-like aggregation of Dpl.
    Erlich P; Cesbron JY; Lemaire-Vieille C; Curt A; Andrieu JP; Schoehn G; Jamin M; Gagnon J
    Biochem Biophys Res Commun; 2008 Jan; 365(3):478-83. PubMed ID: 17997980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The toxicity of prion protein fragment PrP(106-126) is not mediated by membrane permeabilization as shown by a M112W substitution.
    Henriques ST; Pattenden LK; Aguilar MI; Castanho MA
    Biochemistry; 2009 May; 48(19):4198-208. PubMed ID: 19301918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generating recombinant C-terminal prion protein fragments of exact native sequence.
    Johanssen VA; Barnham KJ; Masters CL; Hill AF; Collins SJ
    Neurochem Int; 2012 Feb; 60(3):318-26. PubMed ID: 22197912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular cholesterol enrichment prevents prion peptide-induced neuron cell damages.
    Jeong JK; Seol JW; Moon MH; Seo JS; Lee YJ; Kim JS; Park SY
    Biochem Biophys Res Commun; 2010 Oct; 401(4):516-20. PubMed ID: 20875400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.